Decorin is a secreted protein associated with obesity and type 2 diabetes

International Journal of Obesity

Volumn 32, Issue 7, 2008, Pages 1113-1121

  Bolton, K ^a   Segal, D ^a   McMillan, J ^a   Jowett, J ^b   Heilbronn, L ^c   Abberton, K ^d   Zimmet, P ^b   Chisholm, D ^c   Collier, G ^e   Walder, K ^a,e  

^a DEAKIN UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d Bernard O'Brien Institute of Microsurgery   (Australia)

^e ChemGenex Pharmaceuticals   (Australia)

Author keywords

Adipose tissue; Decorin; Psammomys obesus

Indexed keywords

DECORIN; GLUCOSE; INSULIN; MESSENGER RNA;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; UPREGULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; AGED; ANIMALS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; GERBILLINAE; GLUCOSE INTOLERANCE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, ANIMAL; OBESITY; PROTEOGLYCANS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; WAIST-HIP RATIO;

PSAMMOMYS OBESUS;

EID: 47249165160     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.41     Document Type: Article

References (42)

1. O'Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science 2005; 307: 370-373.
2. Taylor SI. Deconstructing type 2 diabetes. Cell 1999; 97: 9-12.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
5. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
7. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-362.
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
10. Barnett M, Collier GR, Collier FM, Zimmet P, O'Dea K. A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus. Diabetologia 1994; 37: 671-676.
11. Bolton KA, Segal D, McMillan J, Sanigorski A, Todd S, Broz I et al. Identifying differentially expressed secreted novel peptides in diabetic skeletal muscle using a signal sequence trap (Abstract). Diabetologia 2005; 48: A196.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
13. Zimmet P. Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 2000; 247: 301-310.
14. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
15. Hishikawa D, Hong YH, Roh SG, Miyahara H, Nishimura Y, Tomimatsu A et al. Identification of genes expressed differentially in subcutaneous and visceral fat of cattle, pig, and mouse. Physiol Genomics 2005; 21: 343-350.
16. Zhang J, Wright W, Bernlohr DA, Cushman SW, Chen X. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am J Physiol Endocrinol Metab 2007; 292: E1433-E1440.
17. Klein DJ, Cohen RM, Rymaszewski Z. Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. J Cell Physiol 1995; 165: 493-502.
18. Nelimarkka L, Salminen H, Kuopio T, Nikkari S, Ekfors T, Laine J et al. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 2001; 158: 345-353.
19. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007; 117: 2362-2368.
20. Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci 2004; 82: 925-934.
21. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol 1988; 4: 229-255.
22. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730-10735.
23. Schonherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW et al. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 1999; 78: 44-55.
24. Jarvelainen HT, Iruela-Arispe ML, Kinsella MG, Sandell LJ, Sage EH, Wight TN. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 1992; 203: 395-401.
25. Burke AP, Jarvelainen H, Kolodgie FD, Goel A, Wight TN, Virmani R. Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol 2004; 17: 482-488.
26. Schonherr E, Sunderkotter C, Schaefer L, Thanos S, Grassel S, Oldberg A et al. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 2004; 41: 499-508.
27. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
28. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002; 21: 4765-4777.
29. Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005; 280: 27935-27948.
30. Kinsella MG, Fischer JW, Mason DP, Wight TN. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem 2000; 275: 13924-13932.
31. Davies Cde L, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc Res 2001; 62: 26-42.
32. Nelimarkka L, Kainulainen V, Schonherr E, Moisander S, Jortikka M, Lammi M et al. Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells. J Biol Chem 1997; 272: 12730-12737.
33. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
34. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53: 1285-1292.
35. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
36. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
37. Comalada M, Cardo M, Xaus J, Valledor AF, Lloberas J, Ventura F et al. Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol 2003; 170: 4450-4456.
38. Koninger J, Giese NA, Bartel M, di Mola FF, Berberat PO, di Sebastiano P et al. The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis. J Clin Pathol 2006; 59: 21-27.
39. Strazynski M, Eble JA, Kresse H, Schonherr E. Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. J Biol Chem 2004; 279: 21266-21270.
40. Uhlin-Hansen L, Wik T, Kjellen L, Berg E, Forsdahl F, Kolset SO. Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 1993; 82: 2880-2889.
41. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001; 98: 2124-2133.
42. Groeneveld TW, Oroszlan M, Owens RT, Faber-Krol MC, Bakker AC, Arlaud GJ et al. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol 2005; 175: 4715-4723.